Global nuclear medicine firm Curium has expanded its U.S. offerings to include xenon-133 gas
Although the application, Xenon-133 for diagnostic inhalation studies to evaluate pulmonary function, lung imaging and blood flow, may not be considered breakthrough imaging, it is an important staple of the nuclear medicine clinical offering. It’s nice to see another company serving the marketplace and offering a sourcing option.
Read the article on Aunt Minnie.